Development and validation of a LC-MS/MS method for assessment of an anti-inflammatory indolinone derivative by in vitro blood-brain barrier models

被引:8
作者
Jaehne, Evelyn A. [1 ]
Eigenmann, Daniela E. [1 ]
Culot, Maxime [2 ]
Cecchelli, Romeo [2 ]
Walter, Fruzsina R. [3 ]
Deli, Maria A. [3 ]
Tremmel, Robin [4 ]
Fricker, Gert [4 ]
Smiesko, Martin [5 ]
Hamburger, Matthias [1 ]
Oufir, Mouhssin [1 ]
机构
[1] Univ Basel, Dept Pharmaceut Sci, Inst Pharmaceut Biol, CH-4056 Basel, Switzerland
[2] Univ Lille Nord France, UArtois, BBB Lab EA 2465, IMPRT IFR114, F-62307 Lens, France
[3] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6726 Szeged, Hungary
[4] Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany
[5] Univ Basel, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Isatis tinctoria; (E,Z)-3-(4-Hydroxy-3,5-dimethoxybenzylidene)indolin-2-one; Anti-inflammatory; LC-MS/MS; Blood-brain barrier (BBB); TINCTORIA LEAF EXTRACTS; P-GLYCOPROTEIN EFFLUX; ISATIS-TINCTORIA; ENDOTHELIAL-CELLS; INHIBITORY-ACTIVITY; KINASE INHIBITORS; PURE TRYPTANTHRIN; DRUG DISCOVERY; PERMEABILITY; SYSTEM;
D O I
10.1016/j.jpba.2014.05.026
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The compound (E,Z)-3-(4-hydroxy-3,5-dimethoxybenzylidene)indolin-2-one (indolinone) was identified from lipophilic woad extracts (Isatis tinctoria L, Brassicaceae) as a compound possessing potent histamine release inhibitory and anti-inflammatory properties [1]. To further evaluate the potential of indolinone in terms of crossing the blood-brain barrier (BBB), we screened the compound in several in vitro cell-based human and animal BBB models. Therefore, we developed a quantitative LC-MS/MS method for the compound in modified Ringer HEPES buffer (RHB) and validated it according to FDA and EMA guidelines [2,3]. The calibration curve of indolinone in the range between 30.0 and 3000 ng/ml was quadratic, and the limit of quantification was 30.0 ng/ml. Dilution of samples up to 100-fold did not affect precision and accuracy. The carry-over was within acceptance criteria. Indolinone proved to be stable in RHB for 3 h at room temperature (RT), and for three successive freeze/thaw cycles. The processed samples could be stored in the autosampler at 10 degrees C for at least 28 h. Moreover, indolinone was stable for at least 16 days in RHB when stored below -65 degrees C. This validation study demonstrates that our method is specific, selective, precise, accurate, and capable to produce reliable results. In the immortalized human BBB mono-culture model, the apparent permeability coefficient from apical to basolateral (P-app A -> B), and the P-app from basolateral to apical (P-app (B -> A)) were 19.2 +/- 0.485 x 10(-6) cm/s and 21.7 +/- 0.326 x 10-6 cm/s, respectively. For the primary rat/bovine BBB co-culture model a P-app (A -> B) Of 27.1 +/- 1.67 x 10(-6) cm/s was determined. In the primary rat BBB triple co-culture model, the P-app A -> B and the P-app (B -> A) were 56.2 +/- 3.63 x 10(-6) cm/s and 34.6 +/- 1.41 x 10(-6) cm/s, respectively. The data obtained with the different models showed good correlation and were indicative of a high BBB permeation potential of indolinone confirmed by in silica prediction calculations. P-glycoprotein (P-gp) interaction for indolinone was studied with the aid of a calcein-AM uptake assay, and by calculation of the efflux ratio (ER) from the bidirectional permeability assays. For both bidirectional BBB models an ER below 2 was calculated, indicating that no active mediated transport mechanism is involved for indolinone. In porcine brain capillary endothelial cells (PBCECs), the calcein-AM uptake assay demonstrated that indolinone is neither a P-gp substrate nor a P-gp inhibitor and is accumulated into cells at high extent. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:235 / 246
页数:12
相关论文
共 51 条
[1]  
[Anonymous], 2011, Science Medicines Health, Guideline on bioanalytical method validation.
[2]   Compound profiling for p-glycoprotein at the blood-brain barrier using a microplate screening system [J].
Bauer, B ;
Miller, DS ;
Fricker, G .
PHARMACEUTICAL RESEARCH, 2003, 20 (08) :1170-1176
[3]  
BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97
[4]   Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: Comparison between primary glial cells and C6 cell line [J].
Boveri, M ;
Berezowski, V ;
Price, A ;
Slupek, S ;
Lenfant, AM ;
Benaud, C ;
Hartung, T ;
Cecchelli, R ;
Prieto, P ;
Dehouck, MP .
GLIA, 2005, 51 (03) :187-198
[5]   In vitro model for evaluating drug transport across the blood-brain barrier [J].
Cecchelli, R ;
Dehouck, B ;
Descamps, L ;
Fenart, L ;
Buée-Scherrer, V ;
Duhem, C ;
Lundquist, S ;
Rentfel, M ;
Torpier, G ;
Dehouck, MP .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (2-3) :165-178
[6]   Inhibitory activity of tryptanthrin on prostaglandin and leukotriene synthesis [J].
Danz, H ;
Stoyanova, S ;
Thomet, OAR ;
Simon, HU ;
Dannhardt, G ;
Ulbrich, H ;
Hamburger, M .
PLANTA MEDICA, 2002, 68 (10) :875-880
[7]   Quantitative determination of the dual COX-2/5-LOX inhibitor tryptanthrin in Isatis tinctoria by ESI-LC-MS [J].
Danz, H ;
Baumann, D ;
Hamburger, M .
PLANTA MEDICA, 2002, 68 (02) :152-157
[8]   Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria [J].
Danz, H ;
Stoyanova, S ;
Wippich, P ;
Brattström, A ;
Hamburger, M .
PLANTA MEDICA, 2001, 67 (05) :411-416
[9]   AN EASIER, REPRODUCIBLE, AND MASS-PRODUCTION METHOD TO STUDY THE BLOOD-BRAIN-BARRIER INVITRO [J].
DEHOUCK, MP ;
MERESSE, S ;
DELORME, P ;
FRUCHART, JC ;
CECCHELLI, R .
JOURNAL OF NEUROCHEMISTRY, 1990, 54 (05) :1798-1801
[10]   Permeability studies on in vitro blood-brain barrier models: Physiology, pathology, and pharmacology [J].
Deli, MA ;
Abraham, CS ;
Kataoka, Y ;
Niwa, M .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2005, 25 (01) :59-127